The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Complement Activation via Alternative Pathway Is Critical in the Development of Laser-Induced Choroidal Neovascularization: Role of Factor B and Factor H
Abstract
The objective of this study was to explore the role of classical, lectin, and alternative pathways of complement activation in laser-induced choroidal neovascularization (CNV). The classical and alternative pathways were blocked in C57BL/6 mice by small interfering RNAs (siRNA) directed against C1q and factor B, respectively. C4−/− mice developed CNV similar to their wild-type controls and inhibition of C1q by siRNA had no effect on the development of CNV. In contrast, CNV was significantly inhibited (p < 0.001) in C5−/− mice and C57BL/6 mice treated with factor B siRNA. Inhibition of the alternative pathway by factor B siRNA resulted in decreased levels of membrane attack complex and angiogenic factors–vascular endothelial growth factor and TGF-β2. Furthermore, factor B was up-regulated in complement sufficient C57BL/6 mice at day 1 postlaser and remained elevated at day 7. Significantly reduced levels of factor H were observed at day 3 in these animals. In conclusion, our results demonstrate that activation of the factor B-dependent alternative pathway, but not the classical or lectin pathways, was essential for the development of CNV in mouse model of laser-induced CNV. Thus, specific blockade of the alternative pathway may represent a therapeutically relevant strategy for the inhibition of CNV.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several experiments using mouse models of laser-induced CNV have demonstrated that all complement pathways, particularly the alternative and terminal pathways, play a significant role in angiogenesis [150,152,153,154,155,156,157,158,159,160,161,162,163].”
From Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration (2023) · cites this paper as [154]
Citations
Cites
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
Ferris, F. L., Fine, S., & Hyman, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040031330019 · Cited by 1,109
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The codependence of angiogenesis and chronic inflammation
Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 692
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
The role of complement in inflammation and phagocytosis
Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 505
Immunological and Aetiological Aspects of Macular Degeneration
Penfold, P. L., Madigan, M. C., Gillies, M. C., & Provis, J. M. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00025-2 · Cited by 460
Research works printed but not linked: 38
- 1984, Arch. Ophthalmol., 1640
- 2001, Prog. Retin. Eye Res., 227
- 2000, J. Cell. Physiol., 301
- 2000, J. Med. Genet., 83
- 2002, Ophthalmol. Clin. North Am., 87
- 2005, J. Immunol., 491
- 1991, Immunol. Today, 322
- 1995, Crit. Rev. Clin. Lab. Sci., 265
- 1995, Invest. Ophthalmol. Vis. Sci., 2110
- 1990, Invest. Ophthalmol. Vis. Sci., 899
- 2003, Proc. Natl. Acad. Sci. USA, 2679
- 1999, J. Appl. Physiol., 2357
- 1993, Curr. Opin. Immunol., 83
- 1980, Clinical Immunology, 219
- 2004, Biochem. Soc. Trans., 21
- 1997, FASEB J., 457
- 1994, Invest. Ophthalmol. Vis. Sci., 3974
- 2001, Prog. Retin. Eye Res., 385
- 1997, Graefes Arch. Clin. Exp. Ophthalmol., 313
- 1999, Mol. Vis., 26
- 2002, Drugs Aging, 101
- 2004, Nucleic Acids Res., e49
- 2003, Mol. Vis., 210
- 2004, Am. J. Pathol., 2177
- 2004, Lancet Neurol., 145
- 2002, Drug Discov. Today, 1040
- 2004, Clin. Cancer Res., 3667
- 1987, Immunol. Today, 212
- 1991, Immunol. Today, 301
- 2004, Rev. Hosp. Clin. Fac. Med. Sao Paulo, 138
- 2005, Science, 385
- 2005, Science, 421424
- 2005, Science, 419
- 2006, Nat. Genet., 458
- 2001, Exp. Eye Res., 887
- 2000, FASEB J., 835
- 2000, Exp. Eye Res., 441
- 2006, FEBS J., 1403
Cited by
Sorted by citations
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 784
Complement and Its Receptors: New Insights into Human Disease
Holers, V. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120154 · Cited by 430
Animal models of age related macular degeneration
Pennesi, M. E., Neuringer, M., & Courtney, R. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.003 · Cited by 391
“Subretinal injection induced CNV. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 500 5.2.”
MethodInfluentialReynolds, R., Hartnett, M. E., Atkinson, J. P., Giclas, P. C., Rosner, B., & Seddon, J. M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3928 · Cited by 294
Miller, J. W. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.10.018 · Cited by 254
The Membrane Attack Complex in Aging Human Choriocapillaris
Mullins, R. F., Schoo, D. P., Sohn, E. H., Flamme‐Wiese, M. J., Workamelahu, G., Johnston, R. M., Wang, K., Tucker, B. A., & Stone, E. M. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.07.017 · Cited by 236
Mediators of ocular angiogenesis
Qazi, Y., Maddula, S., & Ambati, B. K. (2009) · Journal of Genetics · doi:10.1007/s12041-009-0068-0 · Cited by 175
Immunopathological aspects of age-related macular degeneration
Patel, M. M., & Chan, C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 167
Complement factor H in AMD: Bridging genetic associations and pathobiology
Toomey, C. B., Johnson, L. V., & Rickman, C. B. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.001 · Cited by 162
Rohrer, B., Long, Q., Coughlin, B., Wilson, R. B., Huang, Y., Qiao, F., Tang, P. H., Kunchithapautham, K., Gilkeson, G. S., & Tomlinson, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2222 · Cited by 154
C1q as a unique player in angiogenesis with therapeutic implication in wound healing
Bossi, F., Tripodo, C., Rizzi, L., Bulla, R., Agostinis, C., Guarnotta, C., Munaut, C., Baldassarre, G., Papa, G., Zorzet, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311968111 · Cited by 161
Age-related macular degeneration and the immune response: implications for therapy
Nussenblatt, R. B., & Ferris, F. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.025 · Cited by 130
The role of complement system in ocular diseases including uveitis and macular degeneration
Jha, P., Bora, P. S., & Bora, N. S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.145 · Cited by 134
Self-citationLechner, J., Chen, M., Hogg, R. E., Tóth, L., Silvestri, G., Chakravarthy, U., & Xu, H. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0060-5 · Cited by 114
Wang, J., Ohno‐Matsui, K., Yoshida, T., Shimada, N., Ichinose, S., Sato, T., Mochizuki, M., & Morita, I. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21742 · Cited by 108
Ao, J., Wood, J. P. M., Chidlow, G., Gillies, M. C., & Casson, R. J. (2017) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13121 · Cited by 104
The Role of the Immune Response in Age-Related Macular Degeneration
Whitcup, S. M., Sodhi, A., Atkinson, J. P., Holers, V. M., Sinha, D., Rohrer, B., & Dick, A. D. (2013) · International Journal of Inflammation · doi:10.1155/2013/348092 · Cited by 103
Danis, R. P., Lavine, J. A., & Domalpally, A. (2015) · Clinical ophthalmology · doi:10.2147/opth.s92359 · Cited by 100
Developments in anti-complement therapy; from disease to clinical trial
Harris, C. L., Pouw, R. B., Kavanagh, D., Sun, R., & Ricklin, D. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.008 · Cited by 93
Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sivasankar, B., Harris, C. L., Morgan, B. P., & Bora, P. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1783 · Cited by 91
Self-citationEliminating Complement Factor D Reduces Photoreceptor Susceptibility to Light-Induced Damage
Rohrer, B., Guo, Y., Kunchithapautham, K., & Gilkeson, G. S. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0282 · Cited by 91
Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes
Tian, Y., Kijlstra, A., Renes, J., Wabitsch, M., Webers, C. A. B., & Berendschot, T. T. J. M. (2015) · Journal of Ophthalmology · doi:10.1155/2015/430741 · Cited by 90
Autoimmunity in retinal degeneration: Autoimmune retinopathy and age-related macular degeneration
Morohoshi, K., Goodwin, A. M., Ohbayashi, M., & Ono, S. J. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.003 · Cited by 96
Sabbadini, R. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01118.x · Cited by 90
Wang, J., Ohno‐Matsui, K., Yoshida, T., Kojima, A., Shimada, N., Nakahama, K., Safranova, O., Iwata, N., Saido, T. C., Mochizuki, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.712 · Cited by 82
Loyet, K. M., DeForge, L. E., Katschke, K. J., Diehl, L. J., Graham, R., Pao, L. I., Sturgeon, L., Lewin-Koh, S.-C., Hollyfield, J. G., & Campagne, M. V. L. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9587 · Cited by 84
Filho, C. A. D. A. G., Yehoshua, Z., Gregori, G., Nunes, R. P., Penha, F. M., Moshfeghi, A. A., Zhang, K., Feuer, W. J., & Rosenfeld, P. J. (2013) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20131217-01 · Cited by 79
Katschke, K. J., Xi, H., Cox, C., Truong, T., Malato, Y., Lee, W. P., McKenzie, B. S., Arceo, R., Tao, J., Rangell, L. K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25557-8 · Cited by 78
Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation
Poor, S. H., Qiu, Y., Fassbender, E. S., Shen, S., Woolfenden, A. E., Delpero, A. R., Kim, Y., Buchanan, N. M., Gebuhr, T. C., Hanks, S. M., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15067 · Cited by 73
Yang, S., Li, T., Jia, H., Gao, M., Li, Y., Wan, X., Huang, Z., Li, M., Zhai, Y., Li, X., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj2177 · Cited by 71
The role of complement in ocular pathology
Bora, N. S., Jha, P., & Bora, P. S. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0110-y · Cited by 71
Self-citationCoughlin, B., Schnabolk, G., Joseph, K., Raikwar, H., Kunchithapautham, K., Johnson, K., Moore, K., Wang, Y., & Rohrer, B. (2016) · Scientific Reports · doi:10.1038/srep23794 · Cited by 65
Polyethylene Glycol (PEG)-induced Mouse Model of Choroidal Neovascularization
Lyzogubov, V. V., Tytarenko, R. G., Liu, J., Bora, N. S., & Bora, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204701 · Cited by 64
Self-citationTargeting Microglia to Treat Degenerative Eye Diseases
Wang, S. K., & Cepko, C. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843558 · Cited by 66
Kawa, M. P., Machalińska, A., Rogińska, D., & Machaliński, B. (2014) · Journal of Immunology Research · doi:10.1155/2014/483960 · Cited by 65
Rohrer, B., Coughlin, B., Kunchithapautham, K., Long, Q., Tomlinson, S., Takahashi, K., & Holers, V. M. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.016 · Cited by 62
Machalińska, A., Dziedziejko, V., Mozolewska‐Piotrowska, K., Karczewicz, D., Wiszniewska, B., & Machaliński, B. (2009) · Ophthalmic Research · doi:10.1159/000219686 · Cited by 62
Drugs in Phase II clinical trials for the treatment of age-related macular degeneration
Tolentino, M. J., Dennrick, A., John, E. S., & Tolentino, M. S. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.961601 · Cited by 60
Therapeutic targeting of the complement system in age‐related macular degeneration: a review
Troutbeck, R., Al‐Qureshi, S., & Guymer, R. H. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02581.x · Cited by 60
Zeng, S., Whitmore, S. S., Sohn, E. H., Riker, M. J., Wiley, L. A., Scheetz, T. E., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2016) · The Journal of Pathology · doi:10.1002/path.4669 · Cited by 56
Bora, N. S., Jha, P., Lyzogubov, V. V., Kaliappan, S., Liu, J., Tytarenko, R. G., Fraser, D. A., Morgan, B. P., & Bora, P. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.153130 · Cited by 53
Self-citationNew therapeutic targets in atrophic age-related macular degeneration
Petrukhin, K. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.625 · Cited by 53
Expression of Complement Component 3 (C3) from an Adenovirus Leads to Pathology in the Murine Retina
Cashman, S. M., Desai, A., Ramo, K., & Kumar‐Singh, R. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6002 · Cited by 55
Holers, V. M., Rohrer, B., & Tomlinson, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_9 · Cited by 50
Liu, J., Jha, P., Lyzogubov, V. V., Tytarenko, R. G., Bora, N. S., & Bora, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226266 · Cited by 50
Self-citationBora, N. S., Matta, B., Lyzogubov, V. V., & Bora, P. S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.07.012 · Cited by 49
Self-citationRole of Ocular Complement Factor H in a Murine Model of Choroidal Neovascularization
Lyzogubov, V. V., Tytarenko, R. G., Jha, P., Liu, J., Bora, N. S., & Bora, P. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091168 · Cited by 50
Self-citationBorucki, D. M., Toutonji, A., Couch, C., Mallah, K., Rohrer, B., & Tomlinson, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566892 · Cited by 46
Hu, W., Criswell, M. H., Fong, S., Temm, C. J., Gangaraju, R., Cornell, T. L., & Clauss, M. A. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.10.014 · Cited by 46
Complement System and Potential Therapeutics in Age-Related Macular Degeneration
Park, Y. G., Park, Y. S., & Kim, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136851 · Cited by 51
Angiogenesis in eye disease: immunity gained or immunity lost?
Ferguson, T. A., & Apte, R. S. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0113-8 · Cited by 46
Lyzogubov, V. V., Bora, P. S., Wu, X., Horn, L. E., de Roque, R., Rudolf, X. V., Atkinson, J. P., & Bora, N. S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.03.021 · Cited by 45
Self-citationHammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44
Chowers, I., Cohen, Y., Goldenberg‐Cohen, N., Vicuna-kojchen, J., Lichtinger, A. D., Weinstein, O., Pollack, A., Axer‐Siegel, R., Hemo, I., Averbukh, E., et al. (2008) · PubMed Central · Cited by 45
Bora, P. S., Kaliappan, S., Lyzogubov, V. V., Tytarenko, R. G., Thotakura, S., Viswanathan, T., & Bora, N. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.024 · Cited by 44
Self-citationQin, S., & Rodrigues, G. A. (2008) · Journal of Inflammation Research · doi:10.2147/jir.s4354 · Cited by 43
Emerging therapies and their delivery for treating age‐related macular degeneration
Thomas, C. N., Sim, D. A., Lee, W. H., Alfahad, N., Dick, A. D., Denniston, A. K., & Hill, L. J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15459 · Cited by 46
Complement Regulatory Protein CD46 Protects against Choroidal Neovascularization in Mice
Lyzogubov, V., Wu, X., Jha, P., Tytarenko, R., Triebwasser, M., Kolar, G., Bertram, P., Bora, P. S., Atkinson, J. P., & Bora, N. S. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.06.001 · Cited by 41
Self-citationAge-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
Warwick, A., Khandhadia, S., Ennis, S., & Lotery, A. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041234 · Cited by 42
Rohrer, B., Coughlin, B. A., Bandyopadhyay, M., & Holers, V. M. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0212 · Cited by 42
Schnabolk, G., Parsons, N., Obert, E., Annamalai, B., Nasarre, C., Tomlinson, S., Lewin, A. S., & Rohrer, B. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.003 · Cited by 43
Ramo, K., Cashman, S. M., & Kumar-Singh, R. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2025 · Cited by 38
Schnabolk, G., Coughlin, B., Joseph, K., Kunchithapautham, K., Bandyopadhyay, M., O'Quinn, E. C., Nowling, T., & Rohrer, B. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-15910 · Cited by 37
Jensen, E. G., Jakobsen, T. S., Thiel, S., Askou, A. L., & Corydon, T. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249752 · Cited by 40
Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway
Dreismann, A. K., Hallam, T. M., Tam, L. C. S., Nguyen, C. V., Hughes, J. P., Ellis, S., & Harris, C. L. (2022) · Immunological Reviews · doi:10.1111/imr.13149 · Cited by 36
Complement Involvement in Neovascular Ocular Diseases
Yanai, R., Thanos, A., & Connor, K. M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_10 · Cited by 35
Gu, L., Chen, H., Tuo, J., Gao, X., & Chen, L. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.06.019 · Cited by 33
Lau, L.-I., Chiou, S., Liu, C. J.-L., Yen, M., & Wei, Y. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7815 · Cited by 30
Intravitreal human complement factor H in a rat model of laser-induced choroidal neovascularisation
Kim, S. J., Kim, J., Lee, J.-Y., Cho, S. Y., Kang, H. J., Kim, K.-Y., & Jin, D. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302307 · Cited by 30
Rohrer, B., Long, Q., Coughlin, B. A., Renner, B., Huang, Y. J., Kunchithapautham, K., Ferreira, V. P., Pangburn, M. K., Gilkeson, G. S., Thurman, J. M., et al. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_10 · Cited by 30
Inomata, Y., Tanihara, H., Tanito, M., Okuyama, H., Hoshino, Y., Kinumi, T., Kawaji, T., Kondo, N., Yodoi, J., & Nakamura, H. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1659 · Cited by 25
Loss of Complement Factor H in Plasma Increases Endothelial Cell Migration
Liu, J., & Hoh, J. J. (2017) · Journal of Cancer · doi:10.7150/jca.19452 · Cited by 24
Lutein and Factor D: Two intriguing players in the field of age-related macular degeneration
Tian, Y., Kijlstra, A., Webers, C. A. B., & Berendschot, T. T. J. M. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.01.019 · Cited by 24
Grossman, T. R., Carrer, M., Shen, L., Johnson, R. B., Hettrick, L. A., Henry, S. P., Monia, B. P., & McCaleb, M. L. (2017) · Europe PMC (PubMed Central) · Cited by 22
Kaliappan, S., Jha, P., Lyzogubov, V. V., Tytarenko, R. G., Bora, N. S., & Bora, P. S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.09.009 · Cited by 21
Self-citationPeri-implantitis fibroblasts respond to host immune factor C1q
Verardi, S., Quaranta, M., & Bordin, S. (2010) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2010.01323.x · Cited by 20
Zhang, Y., Huang, Q. B., Tang, M., Zhang, J., & Fan, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129945 · Cited by 20
Manickam, B., Jha, P., Matta, B., Liu, J., Bora, P. S., & Bora, N. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.197616 · Cited by 19
Self-citationDemos, C., Bandyopadhyay, M., & Rohrer, B. (2008) · PubMed Central · Cited by 19
Peplow, P., & Martinez, B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.295271 · Cited by 19
Schmack, I., Berglin, L., Nie, X., Wen, J., Kang, S. J., Marcus, A. I., Yang, H., Lynn, M., Kapp, J. A., & Grossniklaus, H. E. (2009) · PubMed Central · Cited by 19
Inhibitory role of adiponectin peptide I on rat choroidal neovascularization
Lyzogubov, V. V., Tytarenko, R. G., Bora, N. S., & Bora, P. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.017 · Cited by 18
Self-citationMullins, R. F., Warwick, A., Sohn, E. H., & Lotery, A. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx181 · Cited by 19
Brandli, A. A., Khong, F. L., Kong, R. C. K., Kelly, D. J., & Fletcher, E. L. (2022) · Scientific Reports · doi:10.1038/s41598-022-04845-4 · Cited by 18
Mo, F., Ma, X., Liu, X., Zhou, R., Zhao, Y., & Zhou, H. (2019) · Journal of Oncology · doi:10.1155/2019/3283629 · Cited by 15
The Complement System as a Therapeutic Target in Retinal Disease
Ong, J., Zarnegar, A., Selvam, A., Driban, M., & Chhablani, J. K. (2024) · Medicina · doi:10.3390/medicina60060945 · Cited by 14
AICAR suppresses TNF-α-induced complement factor B in RPE cells
Chung, E. J., Efstathiou, N. E., Konstantinou, E. K., Maidana, D. E., Miller, J. W., YOUNG, L. H. Y., & Vavvas, D. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-17744-w · Cited by 14
Cheng, X., He, D., Liao, C., Lin, S., Tang, L., Wang, Y., Hu, J., Li, W. S., Liu, Z., Wu, Y., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30103 · Cited by 14
Antisense Oligonucleotide Therapy for Ophthalmic Conditions
Ferenchak, K., Deitch, I., & Huckfeldt, R. M. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1914116 · Cited by 14
Manickam, B., Jha, P., Hepburn, N. J., Morgan, B. P., Harris, C. L., Bora, P. S., & Bora, N. S. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.08.006 · Cited by 14
Self-citationChoi, J. A., Hwang, J., Yoon, Y. H., & Koh, J. (2013) · Metallomics · doi:10.1039/c3mt00150d · Cited by 14
Complement factor H in molecular regulation of angiogenesis
Li, J., Wang, K., Starodubtseva, M. N., Nadyrov, E. A., Kapron, C. M., Hoh, J. J., & Liu, J. (2024) · Medical Review · doi:10.1515/mr-2023-0048 · Cited by 15
Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal neovascularization
Jo, D. H., Kim, J. H., Yang, W., Kim, H., Chang, S.-J., Kim, D., Chang, M., Lee, K., Chung, J., & Kim, J. H. (2017) · Oncotarget · doi:10.18632/oncotarget.17221 · Cited by 13
Chrzanowska, M., Modrzejewska, A., & Modrzejewska, M. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.11.19 · Cited by 14
Suppression of Choroidal Neovascularization by Dendritic Cell Vaccination Targeting VEGFR2
Mochimaru, H., Nagai, N., Hasegawa, G., Kudo‐Saito, C., Yaguchi, T., Usui, Y., Kurihara, T., Koto, T., Satofuka, S., Shinoda, H., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0425 · Cited by 13
The role of the cytokine TNF-α in choroidal neovascularization: a systematic review
Papadopoulos, Z. (2023) · Eye · doi:10.1038/s41433-023-02634-5 · Cited by 12
Aspirin and age related macular degeneration; the possible relationship.
Wu, Y. T., Zhu, W. J., Li, Y., & Yu, J. (2013) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 12
Complement C3a: Shaping the Plasticity of the Post-stroke Brain
Stokowska, A., & Pekna, M. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-66679-2_26 · Cited by 11
Wu, C. S.-Y., Mikhail, S., Wei, L., Timmers, C. D., Tahiri, S., Neal, A., Walker, J. P., El-Dika, S. S., Blazer, M. A., Rock, J. B., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.197 · Cited by 11
Functional Evaluation of AMD-Associated Risk Variants of Complement Factor B
Pilotti, C., Greenwood, J., & Moss, S. E. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.5.19 · Cited by 10
Metadata
- Authors
- Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sohn, J.-H., Dhaulakhandi, D. B., Kaplan, H. J., & Bora, P. S.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- University of Louisville (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-08-01
- Volume
- 177
- Issue
- 3
- Pages
- 1872-1878
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1585939626
- Cited by
- 124
- References
- 37
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 7 · 2019: 1 · 2018: 5 · 2017: 11 · 2016: 5 · 2015: 8 · 2014: 9 · 2013: 4 · 2012: 12
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY013335, R01EY014623, EY 014623, EY-13335)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- choroidal neovascularization, laser-induced CNV, alternative complement pathway, factor B, complement factor H, complement activation, C1q, C5, membrane attack complex, angiogenesis, vascular endothelial growth factor, TGF-beta2, siRNA knockdown
- MeSH terms
- Animals, Complement Pathway, Alternative, Complement C4, Complement C5, Injections, Intravenous, Lasers, Male, Mice, Inbred C57BL, Complement Factor B, Down-Regulation, Up-Regulation, Complement C1q, Complement Membrane Attack Complex, Transforming Growth Factor beta, Complement Factor H, Mice, Knockout, Choroidal Neovascularization, RNA, Small Interfering, Vascular Endothelial Growth Factor A, Mice, Transforming Growth Factor beta2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review